These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 28730986)

  • 21. Trends and outcomes of device-related 30-day readmissions after left ventricular assist device implantation.
    Briasoulis A; Ueyama H; Kuno T; Asleh R; Alvarez P; Malik AH
    Eur J Intern Med; 2021 Feb; 84():56-62. PubMed ID: 33039191
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Better With Time: An Economic Assessment of Long-Term Mechanical Circulatory Support in a Population Surviving at Least 1 Year with a Left Ventricular Assist Device.
    Chung JJ; Stetson R; Gordon J; Chen CW; Gaffey AC; Rame JE; Acker M; Atluri P
    Semin Thorac Cardiovasc Surg; 2020 Winter; 32(4):738-746. PubMed ID: 30308249
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Durability of left ventricular assist devices: Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) 2006 to 2011.
    Holman WL; Naftel DC; Eckert CE; Kormos RL; Goldstein DJ; Kirklin JK
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):437-41.e1. PubMed ID: 23490245
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Midterm outcome of implantable left ventricular assist devices as a bridge to transplantation: Single-center experience in Japan.
    Kimura M; Kinoshita O; Nawata K; Nishimura T; Hatano M; Imamura T; Endo M; Kagami Y; Kubo H; Kashiwa K; Kinugawa K; Kyo S; Komuro I; Ono M
    J Cardiol; 2015 May; 65(5):383-9. PubMed ID: 25034705
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
    John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Readmissions after ventricular assist device: etiologies, patterns, and days out of hospital.
    Forest SJ; Bello R; Friedmann P; Casazza D; Nucci C; Shin JJ; D'Alessandro D; Stevens G; Goldstein DJ
    Ann Thorac Surg; 2013 Apr; 95(4):1276-81. PubMed ID: 23481701
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intensive Care Unit Readmission After Left Ventricular Assist Device Implantation: Causes, Associated Factors, and Association With Patient Mortality.
    Hui J; Mauermann WJ; Stulak JM; Hanson AC; Maltais S; Barbara DW
    Anesth Analg; 2019 Jun; 128(6):1168-1174. PubMed ID: 31094784
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Readmissions Following Implantation of a Continuous-Flow Left Ventricular Assist Device.
    Da Silva M; MacIver J; Rodger M; Jaffer M; Raju S; Billia F; Rao V
    J Card Surg; 2016 May; 31(5):361-4. PubMed ID: 27072942
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dynamic Forecasts of Survival for Patients Living With Destination Left Ventricular Assist Devices: Insights From INTERMACS.
    Michelis KC; Zhong L; Peltz M; Pandey A; Tang WHW; Rohatgi A; Young JB; Drazner MH; Grodin JL
    J Am Heart Assoc; 2020 Jul; 9(14):e016203. PubMed ID: 32648531
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early Right Ventricular Assist Device Use in Patients Undergoing Continuous-Flow Left Ventricular Assist Device Implantation: Incidence and Risk Factors From the Interagency Registry for Mechanically Assisted Circulatory Support.
    Kiernan MS; Grandin EW; Brinkley M; Kapur NK; Pham DT; Ruthazer R; Rame JE; Atluri P; Birati EY; Oliveira GH; Pagani FD; Kirklin JK; Naftel D; Kormos RL; Teuteberg JJ; DeNofrio D
    Circ Heart Fail; 2017 Oct; 10(10):. PubMed ID: 29021348
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Readmissions after Acute Kidney Injury during Left Ventricular Assist Device Implantation Hospitalization.
    Walther CP; Winkelmayer WC; Deswal A; Niu J; Navaneethan SD
    Am J Nephrol; 2020; 51(3):172-181. PubMed ID: 31962311
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Unplanned hospital readmissions following HeartMate 3 implantation: Readmission rates, causes, and impact on survival.
    Shih H; Mondellini GM; Kurlansky PA; Sun J; Ning Y; Feldman VR; Tiburcio M; Maguire CW; Ladanyi A; Clerkin K; Naka Y; Sayer GT; Uriel N; Colombo PC; Takeda K; Yuzefpolskaya M
    Artif Organs; 2024 Sep; 48(9):1049-1059. PubMed ID: 38825957
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A multicenter analysis of clinical hemolysis in patients supported with durable, long-term left ventricular assist device therapy.
    Katz JN; Jensen BC; Chang PP; Myers SL; Pagani FD; Kirklin JK
    J Heart Lung Transplant; 2015 May; 34(5):701-9. PubMed ID: 25582036
    [TBL] [Abstract][Full Text] [Related]  

  • 34. National Landscape of Hospitalizations in Patients with Left Ventricular Assist Device. Insights from the National Readmission Database 2010-2015.
    Lemor A; Michaels A; Al-Darzi W; Hernandez GA; Nasr Y; Villablanca P; Blumer V; Tita C; Williams CT; Selektor Y; Lanfear DE; Lindenfeld J; Cowger J
    ASAIO J; 2020; 66(10):1087-1094. PubMed ID: 33136594
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Left ventricular assist devices: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2004; 4(3):1-69. PubMed ID: 23074453
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients: The ROADMAP Study 2-Year Results.
    Starling RC; Estep JD; Horstmanshof DA; Milano CA; Stehlik J; Shah KB; Bruckner BA; Lee S; Long JW; Selzman CH; Kasirajan V; Haas DC; Boyle AJ; Chuang J; Farrar DJ; Rogers JG;
    JACC Heart Fail; 2017 Jul; 5(7):518-527. PubMed ID: 28396040
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Morbidity and mortality in heart transplant candidates supported with mechanical circulatory support: is reappraisal of the current United network for organ sharing thoracic organ allocation policy justified?
    Wever-Pinzon O; Drakos SG; Kfoury AG; Nativi JN; Gilbert EM; Everitt M; Alharethi R; Brunisholz K; Bader FM; Li DY; Selzman CH; Stehlik J
    Circulation; 2013 Jan; 127(4):452-62. PubMed ID: 23271796
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pre-Operative Right Ventricular Dysfunction Is Associated With Gastrointestinal Bleeding in Patients Supported With Continuous-Flow Left Ventricular Assist Devices.
    Sparrow CT; Nassif ME; Raymer DS; Novak E; LaRue SJ; Schilling JD
    JACC Heart Fail; 2015 Dec; 3(12):956-64. PubMed ID: 26577618
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors Associated With Prolonged Survival in Left Ventricular Assist Device Recipients.
    Xia Y; Forest S; Friedmann P; Chou LC; Patel S; Jorde U; Goldstein D
    Ann Thorac Surg; 2019 Feb; 107(2):519-526. PubMed ID: 30316851
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical Implications of Respiratory Failure in Patients Receiving Durable Left Ventricular Assist Devices for End-Stage Heart Failure.
    Miller PE; Caraballo C; Ravindra NG; Mezzacappa C; McCullough M; Gruen J; Levin A; Reinhardt S; Ali A; Desai NR; Ahmad T
    Circ Heart Fail; 2019 Nov; 12(11):e006369. PubMed ID: 31707800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.